US Stock MarketDetailed Quotes

MED Medifast

Watchlist

14.165
+0.145+1.03%

Trading Mar 4 12:50 ET

154.93MMarket Cap74.55P/E (TTM)

Medifast Stock Forum

Jaguar8

Jan 7 07:33

NEWS

$Medifast (MED.US)$
Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off
Tuesday, 7th January at 8:30 am
Two new programs incorporate OPTAVIA ASCEND products for easy nutrition, with or without medications, and provide strategies & support to help with weight maintenance
High-protein products help preserve lean muscle mass during weight loss, addressing the accelerated muscle loss often associated with GLP-1 medication...

Clintzilla

Sep 15, 2024 08:56

$Medifast (MED.US)$ weeeeeeeeeeeeee

NCar

Aug 28, 2024 18:26

$Medifast (MED.US)$ when all the people get the shots to get skinny they will need medifast again to maintain their weight so holding on they will bounce back strong, I have faith in this company... :)

doge1m

Jul 12, 2024 11:34

$Medifast (MED.US)$ what's going on here we're getting shorted? This is a great company let's go $20

Ann_Doe

Jun 12, 2024 16:04

Interesting

$Medifast (MED.US)$ wow, so many shorted 🧐

Insider share sale and more insider sales than purchases over the past year may raise concerns. Low insider ownership in Medifast could suggest a lack of long-term incentive to grow the company.

Independent Director Scott Schlackman Sold A Bunch Of Shares In Medifast

Jaymonie

Feb 21, 2024 07:02

LOW FLOAT Squeeze $med

$NVIDIA (NVDA.US)$
check out this company!!
$Medifast (MED.US)$
96.7% institutional ownership
17.9% float sold short
p/e ratio: 4.46
dividend: 13%
0 debt
150 m in cash
established: 1981
$Tesla (TSLA.US)$

Moomoo AI

Feb 20, 2024 15:52

Medifast's decision to increase marketing spending amid demand headwinds has alarmed investors, leading to a 10.1% drop in the company's stock price, despite exceeding revenue expectations.

Medifast (NYSE:MED) Exceeds Q4 Expectations But Stock Drops 10.1%

Moomoo AI

Feb 6, 2024 08:43

Medifast's low P/E ratio is likely due to market anticipation of continued poor earnings. The weak earnings outlook is pressuring the stock price downwards. Without improvement, the low P/E ratio and stock price may not rise.